Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01390610 · ClinicalTrials.gov registry record
Continuous Glucose Monitoring Self-Monitored Blood Glucose Type 2 Therapy Matrix Definition
A clinical trial, sponsored by HealthPartners Institute.
- Completed
- Registry status
- 27
- Enrollment target
NCT01390610 is a clinical trial that has completed, run by HealthPartners Institute. The registered enrollment target is 27 participants.
The verdict
NCT01390610 has completed, sponsored by HealthPartners Institute.
- COMPLETED
- Registry status
- 27 participants
- Enrollment target
Study Summary
The purpose of this study is to use data from the Continuous Glucose Monitoring (CGM) device and your Self-Monitored Blood Glucose (SMBG) levels to determine the best times to test blood glucose levels using SMBG.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2011-06 |
| Est. Completion | 2013-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01390610
The ClinicalTrials.gov registry entry for NCT01390610 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is HealthPartners Institute, which has 146 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01390610 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01390610 about?
NCT01390610 is a clinical study titled "Continuous Glucose Monitoring Self-Monitored Blood Glucose Type 2 Therapy Matrix Definition". The purpose of this study is to use data from the Continuous Glucose Monitoring (CGM) device and your Self-Monitored Blood Glucose (SMBG) levels to determine the best times to test blood glucose levels using SMBG.
What is the current status of trial NCT01390610?
This trial is currently completed. The enrollment target is 27 participants. The study started on 2011-06. Estimated completion is 2013-01.
Who is sponsoring clinical trial NCT01390610?
This trial is sponsored by HealthPartners Institute, which has 146 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.